Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.05 (0.55%)
Spread: 0.70 (7.955%)
Open: 9.10
High: 9.15
Low: 8.70
Prev. Close: 9.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

1 Mar 2017 07:00

RNS Number : 1310Y
Scancell Holdings Plc
01 March 2017
 

TR-1: notification of major interests in shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

Scancell Holdings Plc

2. Reason for the notification  (please tick the appropriate box or boxes)

An acquisition or disposal of voting rights

ü

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An event changing the breakdown of voting rights

Other (please specify):___________________________________________

3. Full name of person(s) subject to the notification obligation:

Helium Special Situations Fund

4. Full name of shareholder(s) (if different from 3.):

 

5. Date of the transaction (and date on which the threshold is crossed or reached if different):

16/02/2017

6. Date on which issuer notified:

28/02/2017

7. Threshold(s) that is/are crossed or reached:

3%

8. Notified details:

 

n/a

 

 

A: Voting rights attached to shares

Class/type of shares

 if possible using the ISIN CODE

Situation previous to the Triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB00B63D3314

8'275'000

8'275'000

4'908'080

4'908'080

 -

1.88%

-

 

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

-

-

-

-

-

 

Total (A+B)

Number of voting rights

% of voting rights

4'908'080

1.88%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

n/a

 

Proxy Voting:

10. Name of the proxy holder:

n/a

11. Number of voting rights proxy holder will cease to hold:

n/a

12. Date on which proxy holder will cease to hold voting rights:

n/a

 

13. Additional information:

-

14. Contact name:

Christian Benz, ISPartners (Co-Advisor to the Helium Special Situations Fund)

15. Contact telephone number:

+41 43 888 7342

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFVTFLITFID
Date   Source Headline
5th Oct 20214:22 pmRNSFirst subject dosed in COVIDITY clinical trial
9th Sep 20214:31 pmRNSPDMR dealing
26th Aug 20217:00 amRNSModi-1 Phase I/II CTA approved by MHRA
17th Aug 20217:00 amRNSScancell selects PharmaJet’s Needle-free Systems
30th Jul 20219:52 amRNSDirector Dealing
29th Jul 20217:00 amRNSCOVIDITY Phase 1 trial application in SA approved
28th Jul 20215:00 pmRNSLindy Durrant appointed CEO of Scancell
22nd Jun 20217:00 amRNSCOVIDITY trial planned in South Africa and UK
15th Jun 20217:00 amRNSAppointment of Joint Broker
8th Jun 20214:41 pmRNSSecond Price Monitoring Extn
8th Jun 20214:35 pmRNSPrice Monitoring Extension
7th Jun 20218:49 amRNSDirector Dealing
30th Apr 202110:48 amRNSDirector Dealing
10th Mar 20219:58 amRNSHolding(s) in Company
2nd Mar 20214:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:35 pmRNSPrice Monitoring Extension
19th Feb 20213:00 pmRNSDirector Dealing
19th Feb 20217:00 amRNSDirector Dealing
17th Feb 20212:04 pmRNSDirector Dealing
16th Feb 20213:00 pmRNSBLOCK LISTING SIX MONTHLY RETURN
15th Feb 20213:36 pmRNSStatement regarding share price movement
15th Feb 202111:05 amRNSSecond Price Monitoring Extn
15th Feb 202111:00 amRNSPrice Monitoring Extension
15th Feb 20219:05 amRNSSecond Price Monitoring Extn
15th Feb 20219:00 amRNSPrice Monitoring Extension
3rd Feb 20217:00 amRNSUpdate on SCIB2 clinical development partnership
29th Jan 20217:00 amRNSInterim Results for the 6 months ended 31 Oct 2020
30th Dec 20202:00 pmRNSPrice Monitoring Extension
30th Dec 202011:05 amRNSSecond Price Monitoring Extn
30th Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
18th Dec 20202:05 pmRNSSecond Price Monitoring Extn
18th Dec 20202:00 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSCOVID-19 vaccine candidate selected
15th Dec 20203:45 pmRNSDirector Dealing
14th Dec 20201:03 pmRNSDirector Dealing
25th Nov 202011:26 amRNSDirector Dealing
17th Nov 20202:34 pmRNSResults of Annual General Meeting
17th Nov 202012:00 pmRNSAppointment of CMO and Medical Director
13th Nov 202012:36 pmRNSDirector Dealing
10th Nov 20202:44 pmRNSDirector Dealing
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:01 pmRNSPrice Monitoring Extension
6th Nov 202011:49 amRNSHolding(s) in Company
5th Nov 202010:51 amRNSResult of Adjourned General Meeting
3rd Nov 20208:33 amRNSHolding(s) in Company
2nd Nov 20205:00 pmRNSConvertible Loan Notes & Total Voting Rights
29th Oct 202010:15 amRNSResult of Open Offer and Adjournment of GM
27th Oct 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.